ADC Therapeutics S.A. Insider Trading

ADCT

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

No executive or director has bought shares on the open market in the last two years.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

None

in the last two years

Get an email when ADCT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Mar 31 – Apr 2	Redco II Master Fund, L.p. Large holder	SoldNo plan 6 parts	5,880,415	$3.34 average	$19.6M	13%	Form 4
Dec 11, 2024	Jeremy Green Large holder	Bought 4 parts	200,000	$3.05 average	609K	0.7%	Form 4
Dec 4, 2024	Redco II Master Fund, L.p. Large holder	SoldNo plan	25,352	$2.07	52K	<0.1%	Form 4

Mar 31 – Apr 2No plan
Redco II Master Fund, L.p.
Large holder · sold 5,880,415 at avg $3.34
$19.6M
13% of stake
Dec 11, 2024
Jeremy Green
Large holder · bought 200,000 at avg $3.05
609K
0.7% of stake
Dec 4, 2024No plan
Redco II Master Fund, L.p.
Large holder · sold 25,352 at $2.07
52K
<0.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ADCT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ADCT

CompareIntrinsic value

ABCLAbCellera Biologics Inc.

$12.28+0.82%10

ZYMEZymeworks Inc.

$30.98+2.82%10

KURAKura Oncology Inc.

$7.61-22.98%10

PTGXProtagonist Therapeutics Inc.

$143.37+2.23%54

ETONEton Pharmaceuticals Inc.

$50.72-0.45%75

ASMBAssembly Biosciences Inc.

$19.87-0.25%19

VRDNViridian Therapeutics Inc.

$29.06+15.53%40

LXRXLexicon Pharmaceuticals, Inc.

$1.48+1.37%40

Held by ETFs

ADCT is in 4 US ETFs. The largest of them, with ADCT's weight in each:

Spot a number that looks wrong? Check it in ADCT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ADCT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.